1SXP

SCHOTT Pharma AG & Co. KGaA

  • Germany
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions EUR
FY21:
0.30
FY22:
0.55
FY23:
0.47
FY24:
0.59
FY25:
0.68
(positive)
Change from FY21 to FY25
billions EUR
FY21:
0.44
FY22:
0.64
FY23:
0.76
FY24:
0.85
FY25:
0.92
Total assets
Change from FY21 to FY25
billions EUR
FY21:
0.74
FY22:
1.20
FY23:
1.23
FY24:
1.44
FY25:
1.60

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions EUR
FY21:
0.24
FY22:
0.32
FY23:
0.35
FY24:
0.44
FY25:
0.45
(negative)
Change from FY21 to FY25
billions EUR
FY21:
0.08
FY22:
0.16
FY23:
0.19
FY24:
0.21
FY25:
0.25
(positive)
Change from FY21 to FY25
billions EUR
FY21:
0.42
FY22:
0.71
FY23:
0.69
FY24:
0.79
FY25:
0.89
Total liabilities & equity
Change from FY21 to FY25
billions EUR
FY21:
0.74
FY22:
1.20
FY23:
1.23
FY24:
1.44
FY25:
1.60

All amounts in billions EUR Data source:Twelve Data